We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Disposable Robotic System Advances Endovascular Procedures

By HospiMedica International staff writers
Posted on 06 Feb 2020
Image: The Liberty robotic system (Photo courtesy of Microbot Medical)
Image: The Liberty robotic system (Photo courtesy of Microbot Medical)
A fully disposable robotic catheterization system reduces radiation exposure and physical strain to the attending physician.

The Microbot Medical (Yokneam, Israel) Liberty robotic system is a disposable mini-robot strapped to a patients arm that is intended for remote use during neurovascular, cardiovascular, and peripheral vascular procedures. Liberty combines a guidewire and a micro-catheter into a single “One & Done” device that allows linear and rotational motion, as well as tip rotation of the integrated device. An intuitive remote control that resembles a game controller simplifies advanced procedures while shortening the operator’s learning curve.

The system is also ready for tele-catheterization procedures by specialists, and can also provide linear motion for additional over-the-wire devices. Major financial benefits of the device are primarily in the reduction in consumables; and secondly, since it is disposable, there is no reprocessing and sterilization needed.

“Liberty is set to revolutionize the way surgical robotics are being used in endovascular procedures, by eliminating the need for capital equipment, reducing radiation exposure, and aiming to streamline the use of disposables during these complex procedures,” said Harel Gadot, CEO, president, and chairman of Microbot Medical. “With Liberty’s remote operation as well as its ‘One & Done’ capabilities, we believe it has the potential to be the first system to democratize endovascular interventional procedures by shortening the physician’s learning curve.”

“I believe Liberty will be welcomed by the interventional community due to its clinical and technical benefits in various subspecialties, such as neurovascular, cardiovascular, and peripheral vascular interventions,” said interventional radiologist Eyal Morag, MD, of Assuta Medical Center (Ashdod, Israel). “The system set up is easy and straightforward, and it offers intuitive remote operation capabilities designed to reduce radiation exposure and eliminate physical strain on the physicians.”

Related Links:
Microbot Medical

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
MR Trolley
MR9002
New
Trocar
TAN RoTaLock Trocar

Channels

Critical Care

view channel
The intelligent wound dressing consists of a granular hydrogel (Photo courtesy of Apoorv Singh/ETH Zurich)

Intelligent Wound Dressing Reduces Inflammation and Promotes Healing

Chronic wounds, especially those caused by diabetes or circulatory disorders, are a widespread medical problem that burden healthcare systems. Patients often suffer from open skin lesions that fail to... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more